Home › Funds › Ashmore Emerging Markets Active Equity Fund
Fund family: Ashmore Funds · Filed by Ashmore Funds (CIK 1498498) · SEC series S000055437
Share classes and tickers: EMQAX (C000174429), EMQCX (C000174430), EMQIX (C000174431)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 684 with, 1 against, 1 abstentions (not counted as with management); 30 items carried no recommendation. Shareholder proposals: 11 FOR, 5 AGAINST, 1 abstained, by the filing’s own vote-source field.
Each ballot item this fund voted is set against the votes of the other Ashmore Funds funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted the same way as most Ashmore Funds funds on all 202 items where a comparison was possible.
| Proposal type | Items | Against management |
|---|---|---|
| Corporate Governance | 221 | 1 |
| Director Elections | 217 | 0 |
| Capital Structure | 125 | 0 |
| Compensation | 80 | 0 |
| Extraordinary Transactions | 37 | 0 |
| Audit-related | 28 | 0 |
| Other | 6 | 0 |
| Say-on-Pay | 1 | 0 |
| Shareholder Rights and Defenses | 1 | 0 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Dr. Reddy's Laboratories Limited | July 24, 2025 | $360,209 | 6 | 0 |
| PDD Holdings Inc. | December 19, 2025 | $230,893 | 6 | 0 |
| Cognizant Technology Solutions Corporation | June 2, 2026 | $107,139 | 16 | 1 |
| Infosys Limited | November 4, 2025 | $102,298 | 1 | 0 |
| Infosys Limited | May 24, 2026 | $81,875 | 2 | 0 |
| Vista Energy SAB de CV | April 28, 2026 | $51,370 | 9 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| June 2, 2026 | Cognizant Technology Solutions Corporation | Shareholder proposal to adopt shareholder right to act by written consent, if properly presented at the meeting. Shareholder proposal | For | Against |
716 ballot items at 71 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Ashmore Emerging Markets Active Equity Fund (EMQAX) voted at 71 shareholder meetings of 53 companies, on 716 ballot items in all. Where management made a recommendation, the fund followed it on 99.7% of the items and voted against it 1 time. Its most frequent area of disagreement was corporate governance (1 of its votes against management). It voted on 17 shareholder proposals. It voted the same way as most Ashmore Funds funds on every item where a comparison was possible.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026. The interactive database shows the same votes company by company, with every other fund that voted.